4.7 Article

Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

The Inflammasome in Atherosclerosis and Type 2 Diabetes

Seth L. Masters et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Review Medicine, General & Internal

Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome

Ioannis Mitroulis et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)

Review Endocrinology & Metabolism

Blockade of interleukin 1 in type 1 diabetes mellitus

Thomas Mandrup-Poulsen et al.

NATURE REVIEWS ENDOCRINOLOGY (2010)

Article Endocrinology & Metabolism

Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I

Marianne Boeni-Schnetzler et al.

ENDOCRINOLOGY (2009)

Article Immunology

In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes

Helen J. Lachmann et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Medicine, General & Internal

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Helen J. Lachmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Multidisciplinary Sciences

IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat

J. A. Ehses et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Endocrinology & Metabolism

Abnormalities in insulin secretion in type 2 diabetes mellitus

P. -J. Guillausseau et al.

DIABETES & METABOLISM (2008)

Editorial Material Medicine, General & Internal

Rosiglitazone no longer recommended

[Anonymous]

LANCET (2008)

Article Medicine, General & Internal

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Claus M. Larsen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)